Skeletal muscle analysis of cancer patients reveals a potential role for carnosine in muscle wasting
Abstract Background Muscle wasting during cancer cachexia is mediated by protein degradation via autophagy and ubiquitin‐linked proteolysis. These processes are sensitive to changes in intracellular pH ([pH]i) and reactive oxygen species, which in skeletal muscle are partly regulated by histidyl dip...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-08-01
|
| Series: | Journal of Cachexia, Sarcopenia and Muscle |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/jcsm.13258 |
| _version_ | 1797754746030784512 |
|---|---|
| author | Dheeraj Kumar Posa Janice Miller David Hoetker Michael I. Ramage Hong Gao Jingjing Zhao Benjamin Doelling Aruni Bhatnagar Stephen J. Wigmore Richard J.E. Skipworth Shahid P. Baba |
| author_facet | Dheeraj Kumar Posa Janice Miller David Hoetker Michael I. Ramage Hong Gao Jingjing Zhao Benjamin Doelling Aruni Bhatnagar Stephen J. Wigmore Richard J.E. Skipworth Shahid P. Baba |
| author_sort | Dheeraj Kumar Posa |
| collection | DOAJ |
| description | Abstract Background Muscle wasting during cancer cachexia is mediated by protein degradation via autophagy and ubiquitin‐linked proteolysis. These processes are sensitive to changes in intracellular pH ([pH]i) and reactive oxygen species, which in skeletal muscle are partly regulated by histidyl dipeptides, such as carnosine. These dipeptides, synthesized by the enzyme carnosine synthase (CARNS), remove lipid peroxidation‐derived aldehydes, and buffer [pH]i. Nevertheless, their role in muscle wasting has not been studied. Methods Histidyl dipeptides in the rectus abdominis (RA) muscle and red blood cells (RBCs) of male and female controls (n = 37), weight stable (WS: n = 35), and weight losing (WL; n = 30) upper gastrointestinal cancer (UGIC) patients, were profiled by LC–MS/MS. Expression of enzymes and amino acid transporters, involved in carnosine homeostasis, was measured by Western blotting and RT‐PCR. Skeletal muscle myotubes were treated with Lewis lung carcinoma conditioned medium (LLC CM), and β‐alanine to study the effects of enhancing carnosine production on muscle wasting. Results Carnosine was the predominant dipeptide present in the RA muscle. In controls, carnosine levels were higher in men (7.87 ± 1.98 nmol/mg tissue) compared with women (4.73 ± 1.26 nmol/mg tissue; P = 0.002). In men, carnosine was significantly reduced in both the WS (5.92 ± 2.04 nmol/mg tissue, P = 0.009) and WL (6.15 ± 1.90 nmol/mg tissue; P = 0.030) UGIC patients, compared with controls. In women, carnosine was decreased in the WL UGIC (3.42 ± 1.33 nmol/mg tissue; P = 0.050), compared with WS UGIC patients (4.58 ± 1.57 nmol/mg tissue), and controls (P = 0.025). Carnosine was significantly reduced in the combined WL UGIC patients (5.12 ± 2.15 nmol/mg tissue) compared with controls (6.21 ± 2.24 nmol/mg tissue; P = 0.045). Carnosine was also significantly reduced in the RBCs of WL UGIC patients (0.32 ± 0.24 pmol/mg protein), compared with controls (0.49 ± 0.31 pmol/mg protein, P = 0.037) and WS UGIC patients (0.51 ± 0.40 pmol/mg protein, P = 0.042). Depletion of carnosine diminished the aldehyde‐removing ability in the muscle of WL UGIC patients. Carnosine levels were positively associated with decreases in skeletal muscle index in the WL UGIC patients. CARNS expression was decreased in the muscle of WL UGIC patients and myotubes treated with LLC‐CM. Treatment with β‐alanine, a carnosine precursor, enhanced endogenous carnosine production and decreased ubiquitin‐linked protein degradation in LLC‐CM treated myotubes. Conclusions Depletion of carnosine could contribute to muscle wasting in cancer patients by lowering the aldehyde quenching abilities. Synthesis of carnosine by CARNS in myotubes is particularly affected by tumour derived factors and could contribute to carnosine depletion in WL UGIC patients. Increasing carnosine in skeletal muscle may be an effective therapeutic intervention to prevent muscle wasting in cancer patients. |
| first_indexed | 2024-03-12T17:37:02Z |
| format | Article |
| id | doaj.art-c02fd9a25f77491299b8f06183dad31a |
| institution | Directory Open Access Journal |
| issn | 2190-5991 2190-6009 |
| language | English |
| last_indexed | 2024-03-12T17:37:02Z |
| publishDate | 2023-08-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Cachexia, Sarcopenia and Muscle |
| spelling | doaj.art-c02fd9a25f77491299b8f06183dad31a2023-08-04T10:07:00ZengWileyJournal of Cachexia, Sarcopenia and Muscle2190-59912190-60092023-08-011441802181410.1002/jcsm.13258Skeletal muscle analysis of cancer patients reveals a potential role for carnosine in muscle wastingDheeraj Kumar Posa0Janice Miller1David Hoetker2Michael I. Ramage3Hong Gao4Jingjing Zhao5Benjamin Doelling6Aruni Bhatnagar7Stephen J. Wigmore8Richard J.E. Skipworth9Shahid P. Baba10Center for Cardiometabolic Science Louisville Kentucky USADepartment of Clinical Surgery University of Edinburgh Edinburgh UKCenter for Cardiometabolic Science Louisville Kentucky USADepartment of Clinical Surgery University of Edinburgh Edinburgh UKCenter for Cardiometabolic Science Louisville Kentucky USACenter for Cardiometabolic Science Louisville Kentucky USACenter for Cardiometabolic Science Louisville Kentucky USACenter for Cardiometabolic Science Louisville Kentucky USADepartment of Clinical Surgery University of Edinburgh Edinburgh UKDepartment of Clinical Surgery University of Edinburgh Edinburgh UKCenter for Cardiometabolic Science Louisville Kentucky USAAbstract Background Muscle wasting during cancer cachexia is mediated by protein degradation via autophagy and ubiquitin‐linked proteolysis. These processes are sensitive to changes in intracellular pH ([pH]i) and reactive oxygen species, which in skeletal muscle are partly regulated by histidyl dipeptides, such as carnosine. These dipeptides, synthesized by the enzyme carnosine synthase (CARNS), remove lipid peroxidation‐derived aldehydes, and buffer [pH]i. Nevertheless, their role in muscle wasting has not been studied. Methods Histidyl dipeptides in the rectus abdominis (RA) muscle and red blood cells (RBCs) of male and female controls (n = 37), weight stable (WS: n = 35), and weight losing (WL; n = 30) upper gastrointestinal cancer (UGIC) patients, were profiled by LC–MS/MS. Expression of enzymes and amino acid transporters, involved in carnosine homeostasis, was measured by Western blotting and RT‐PCR. Skeletal muscle myotubes were treated with Lewis lung carcinoma conditioned medium (LLC CM), and β‐alanine to study the effects of enhancing carnosine production on muscle wasting. Results Carnosine was the predominant dipeptide present in the RA muscle. In controls, carnosine levels were higher in men (7.87 ± 1.98 nmol/mg tissue) compared with women (4.73 ± 1.26 nmol/mg tissue; P = 0.002). In men, carnosine was significantly reduced in both the WS (5.92 ± 2.04 nmol/mg tissue, P = 0.009) and WL (6.15 ± 1.90 nmol/mg tissue; P = 0.030) UGIC patients, compared with controls. In women, carnosine was decreased in the WL UGIC (3.42 ± 1.33 nmol/mg tissue; P = 0.050), compared with WS UGIC patients (4.58 ± 1.57 nmol/mg tissue), and controls (P = 0.025). Carnosine was significantly reduced in the combined WL UGIC patients (5.12 ± 2.15 nmol/mg tissue) compared with controls (6.21 ± 2.24 nmol/mg tissue; P = 0.045). Carnosine was also significantly reduced in the RBCs of WL UGIC patients (0.32 ± 0.24 pmol/mg protein), compared with controls (0.49 ± 0.31 pmol/mg protein, P = 0.037) and WS UGIC patients (0.51 ± 0.40 pmol/mg protein, P = 0.042). Depletion of carnosine diminished the aldehyde‐removing ability in the muscle of WL UGIC patients. Carnosine levels were positively associated with decreases in skeletal muscle index in the WL UGIC patients. CARNS expression was decreased in the muscle of WL UGIC patients and myotubes treated with LLC‐CM. Treatment with β‐alanine, a carnosine precursor, enhanced endogenous carnosine production and decreased ubiquitin‐linked protein degradation in LLC‐CM treated myotubes. Conclusions Depletion of carnosine could contribute to muscle wasting in cancer patients by lowering the aldehyde quenching abilities. Synthesis of carnosine by CARNS in myotubes is particularly affected by tumour derived factors and could contribute to carnosine depletion in WL UGIC patients. Increasing carnosine in skeletal muscle may be an effective therapeutic intervention to prevent muscle wasting in cancer patients.https://doi.org/10.1002/jcsm.13258AnserineBeta‐alanineHistidyl dipeptidesLipid peroxidation productsUbiquitin |
| spellingShingle | Dheeraj Kumar Posa Janice Miller David Hoetker Michael I. Ramage Hong Gao Jingjing Zhao Benjamin Doelling Aruni Bhatnagar Stephen J. Wigmore Richard J.E. Skipworth Shahid P. Baba Skeletal muscle analysis of cancer patients reveals a potential role for carnosine in muscle wasting Journal of Cachexia, Sarcopenia and Muscle Anserine Beta‐alanine Histidyl dipeptides Lipid peroxidation products Ubiquitin |
| title | Skeletal muscle analysis of cancer patients reveals a potential role for carnosine in muscle wasting |
| title_full | Skeletal muscle analysis of cancer patients reveals a potential role for carnosine in muscle wasting |
| title_fullStr | Skeletal muscle analysis of cancer patients reveals a potential role for carnosine in muscle wasting |
| title_full_unstemmed | Skeletal muscle analysis of cancer patients reveals a potential role for carnosine in muscle wasting |
| title_short | Skeletal muscle analysis of cancer patients reveals a potential role for carnosine in muscle wasting |
| title_sort | skeletal muscle analysis of cancer patients reveals a potential role for carnosine in muscle wasting |
| topic | Anserine Beta‐alanine Histidyl dipeptides Lipid peroxidation products Ubiquitin |
| url | https://doi.org/10.1002/jcsm.13258 |
| work_keys_str_mv | AT dheerajkumarposa skeletalmuscleanalysisofcancerpatientsrevealsapotentialroleforcarnosineinmusclewasting AT janicemiller skeletalmuscleanalysisofcancerpatientsrevealsapotentialroleforcarnosineinmusclewasting AT davidhoetker skeletalmuscleanalysisofcancerpatientsrevealsapotentialroleforcarnosineinmusclewasting AT michaeliramage skeletalmuscleanalysisofcancerpatientsrevealsapotentialroleforcarnosineinmusclewasting AT honggao skeletalmuscleanalysisofcancerpatientsrevealsapotentialroleforcarnosineinmusclewasting AT jingjingzhao skeletalmuscleanalysisofcancerpatientsrevealsapotentialroleforcarnosineinmusclewasting AT benjamindoelling skeletalmuscleanalysisofcancerpatientsrevealsapotentialroleforcarnosineinmusclewasting AT arunibhatnagar skeletalmuscleanalysisofcancerpatientsrevealsapotentialroleforcarnosineinmusclewasting AT stephenjwigmore skeletalmuscleanalysisofcancerpatientsrevealsapotentialroleforcarnosineinmusclewasting AT richardjeskipworth skeletalmuscleanalysisofcancerpatientsrevealsapotentialroleforcarnosineinmusclewasting AT shahidpbaba skeletalmuscleanalysisofcancerpatientsrevealsapotentialroleforcarnosineinmusclewasting |